Procter & Gamble Company (The) $PG Shares Acquired by Capital Management Associates Inc

Capital Management Associates Inc lifted its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 80.1% in the second quarter, Holdings Channel reports. The institutional investor owned 2,952 shares of the company’s stock after buying an additional 1,313 shares during the quarter. Capital Management Associates Inc’s holdings in Procter & Gamble were worth $470,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Kingstone Capital Partners Texas LLC boosted its holdings in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period. Nuveen LLC acquired a new position in Procter & Gamble in the first quarter valued at approximately $1,954,941,000. Price T Rowe Associates Inc. MD boosted its stake in Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after acquiring an additional 2,466,308 shares during the period. Invesco Ltd. boosted its stake in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after acquiring an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC boosted its position in Procter & Gamble by 1,875.5% during the 2nd quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after purchasing an additional 1,674,139 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

PG opened at $150.67 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a market capitalization of $352.64 billion, a price-to-earnings ratio of 23.14, a price-to-earnings-growth ratio of 4.05 and a beta of 0.36. The business has a 50 day moving average price of $155.26 and a two-hundred day moving average price of $159.72. Procter & Gamble Company has a 1-year low of $149.91 and a 1-year high of $180.43.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on PG shares. Evercore ISI restated an “in-line” rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. JPMorgan Chase & Co. reissued a “neutral” rating and set a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research note on Thursday, September 25th. BNP Paribas reissued an “outperform” rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Finally, UBS Group reduced their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research report on Wednesday. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $172.58.

Insider Buying and Selling at Procter & Gamble

In related news, CFO Andre Schulten sold 4,252 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the sale, the chief financial officer directly owned 53,992 shares of the company’s stock, valued at $8,219,202.16. This represents a 7.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jennifer L. Davis sold 3,227 shares of the stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer owned 61,764 shares of the company’s stock, valued at $9,402,333.72. This trade represents a 4.97% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 149,763 shares of company stock valued at $23,421,279. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.